Yoshihiko Takahashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yoshihiko Takahashi has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Hiroyuki Suzuki
Advanced Medical Emergency Department and Critical Care Center, Maebashi Red Cross Hospital, Gunma, Japan
5 shared publicationsKenji Fujizuka
Advanced Medical Emergency Department and Critical Care Center, Maebashi Red Cross Hospital, Gunma, Japan
4 shared publicationsMitsunobu Nakamura
Advanced Medical Emergency Department and Critical Care Center, Maebashi Red Cross Hospital, Gunma, Japan
4 shared publications- Shu Utsumi
Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
3 shared publications - Hajime Watanabe
Department of Biotechnology, Graduate School of Engineering, The University of Osaka, Suita, Japan
2 shared publications - Kenji Fujizuka
Advanced Medical Emergency Department and Critical Care Center Japanese Red Cross Maebashi Hospital Maebashi Japan
2 shared publications
Latest Publications
- Open Access
- 23 October 2025
- Published by Elsevier in International Journal of Nursing Studies Advances
- Vol. 9, 100438
Impact of a decision-making support framework on nurse burnout and quality of end-of-life care: A before-and-after study in intensive care units
- 23 October 2025
- Published by Elsevier in International Journal of Nursing Studies Advances
- Vol. 9, 100438
Open AccessImpact of a decision-making support framework on nurse burnout and quality of end-of-life care: A before-and-after study in intensive care units
- 19 November 2023
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 43 (1) , 101330
Factors associated with healthcare providers' satisfaction with end-of-life care in the intensive care unit: A systematic review
- 19 November 2023
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 43 (1) , 101330
Factors associated with healthcare providers' satisfaction with end-of-life care in the intensive care unit: A systematic review
- Open Access
- 12 January 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (1) , e0267339
Effect of a systematic lung-protective protocol for COVID-19 pneumonia requiring invasive ventilation: A single center retrospective study
The benefits of introducing a systematic lung-protective protocol for coronavirus disease 2019 (COVID-19) pneumonia requiring invasive ventilation in the intensive care unit (ICU) are unknown. Herein, we aimed to evaluate the clinical effects of introducing such a protocol in terms of mortality, duration of ventilation, and length of ICU stay. In this single-centre, retrospective, quality comparison study, we identified patients with COVID-19 pneumonia who received invasive ventilation in our ICU between February 2020 and October 2021. We established a systematic lung-protective protocol for the pre-introduction group until March 2021 and the post-introduction group after April 2021. Patients who did not receive invasive ventilation and who underwent veno-venous extracorporeal membrane oxygenation in a referring hospital were excluded. We collected patient characteristics at the time of ICU admission, including age, sex, body mass index (BMI), comorbidities, sequential organ failure assessment (SOFA) score, acute physiology and chronic health evaluation II (APACHE II) score, and Murray score. The study outcomes were ICU mortality, length of ICU stay, and duration of ventilation. The pre-introduction and post-introduction groups included 18 and 50 patients, respectively. No significant differences were observed in sex, BMI, SOFA score, APACHE II score, and Murray score; however, age was lower in the post-introduction group (70 vs. 56, P = 0.003). The introduction of this protocol did not improve ICU mortality. However, it reduced the ICU length of stay (26 days vs. 11 days, P = 0.003) and tended to shorten the duration of ventilation (15 days vs. 10 days, P = 0.06). The introduction of the protocol was associated with a decrease in the length of ICU stay and duration of ventilation; however, it did not change mortality. The application of the protocol could improve the security of medical resources during the COVID-19 pandemic. Further prospective multicentre studies are needed.
- 12 January 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (1) , e0267339
Open AccessEffect of a systematic lung-protective protocol for COVID-19 pneumonia requiring invasive ventilation: A single center retrospective study
The benefits of introducing a systematic lung-protective protocol for coronavirus disease 2019 (COVID-19) pneumonia requiring invasive ventilation in the intensive care unit (ICU) are unknown. Herein, we aimed to evaluate the clinical effects of introducing such a protocol in terms of mortality, duration of ventilation, and length of ICU stay. In this single-centre, retrospective, quality comparison study, we identified patients with COVID-19 pneumonia who received invasive ventilation in our ICU between February 2020 and October 2021. We established a systematic lung-protective protocol for the pre-introduction group until March 2021 and the post-introduction group after April 2021. Patients who did not receive invasive ventilation and who underwent veno-venous extracorporeal membrane oxygenation in a referring hospital were excluded. We collected patient characteristics at the time of ICU admission, including age, sex, body mass index (BMI), comorbidities, sequential organ failure assessment (SOFA) score, acute physiology and chronic health evaluation II (APACHE II) score, and Murray score. The study outcomes were ICU mortality, length of ICU stay, and duration of ventilation. The pre-introduction and post-introduction groups included 18 and 50 patients, respectively. No significant differences were observed in sex, BMI, SOFA score, APACHE II score, and Murray score; however, age was lower in the post-introduction group (70 vs. 56, P = 0.003). The introduction of this protocol did not improve ICU mortality. However, it reduced the ICU length of stay (26 days vs. 11 days, P = 0.003) and tended to shorten the duration of ventilation (15 days vs. 10 days, P = 0.06). The introduction of the protocol was associated with a decrease in the length of ICU stay and duration of ventilation; however, it did not change mortality. The application of the protocol could improve the security of medical resources during the COVID-19 pandemic. Further prospective multicentre studies are needed.
- 25 November 2022
- Published by Elsevier in Journal of Critical Care
- Vol. 73, 154214
Letter to the editor: “Increased respiratory dead space could associate with coagulation activation and poor outcomes in COVID-19 ARDS”
- 25 November 2022
- Published by Elsevier in Journal of Critical Care
- Vol. 73, 154214
Letter to the editor: “Increased respiratory dead space could associate with coagulation activation and poor outcomes in COVID-19 ARDS”
- Open Access
- 14 November 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (11) , e0277641
Risk factors for mechanical ventilation and ECMO in COVID-19 patients admitted to the ICU: A multicenter retrospective observational study
Background: The primary purpose of this study was to investigate risk factors associated with the need for mechanical ventilation (MV) and extracorporeal membrane oxygenation (ECMO) in COVID-19 patients admitted to the intensive care unit (ICU). Methods: We retrospectively enrolled 66 consecutive COVID-19 patients admitted to the ICUs of three Japanese institutions from February 2020 to January 2021. We performed logistic regression analyses to identify risk factors associated with subsequent MV and ECMO requirements. Further, multivariate analyses were performed following adjustment for Acute Physiology and Chronic Health Evaluation (APACHE) II scores. Results: At ICU admission, the risk factors for subsequent MV identified were: higher age (Odds Ratio (OR) 1.04, 95% Confidence Interval (CI) 1.00–1.08, P = 0.03), higher values of APACHE II score (OR 1.20, 95% CI 1.08–1.33, P < 0.001), Sequential Organ Failure Assessment score (OR 1.53, 95% CI 1.18–1.97, P < 0.001), lactate dehydrogenase (LDH) (OR 1.01, 95% CI 1.00–1.02, p<0.001) and C-reactive protein (OR 1.09, 95% CI 1.00–1.19, P = 0.04), and lower values of lymphocytes (OR 1.00, 95% CI 1.00–1.00, P = 0.02) and antithrombin (OR 0.95, 95% CI 0.91–0.95, P < 0.01). Patients who subsequently required ECMO showed lower values of estimated glomerular filtration rate (OR 0.98, 95% CI 0.96–1.00, P = 0.04) and antithrombin (OR 0.94, 95% CI 0.88–1.00, P = 0.03) at ICU admission. Multivariate analysis showed that higher body mass index (OR 1.19, 95% CI 1.00–1.40, P = 0.04) and higher levels of LDH (OR 1.01, 95% CI 1.01–1.02, P < 0.01) were independent risk factors for the need for MV. Lower level of antithrombin (OR 0.94, 95% CI 0.88–1.00, P = 0.03) was a risk factor for the need for ECMO. Conclusion: We showed that low antithrombin level at ICU admission might be a risk factor for subsequent ECMO requirements, in addition to other previously reported factors.
- 14 November 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (11) , e0277641
Open AccessRisk factors for mechanical ventilation and ECMO in COVID-19 patients admitted to the ICU: A multicenter retrospective observational study
Background: The primary purpose of this study was to investigate risk factors associated with the need for mechanical ventilation (MV) and extracorporeal membrane oxygenation (ECMO) in COVID-19 patients admitted to the intensive care unit (ICU). Methods: We retrospectively enrolled 66 consecutive COVID-19 patients admitted to the ICUs of three Japanese institutions from February 2020 to January 2021. We performed logistic regression analyses to identify risk factors associated with subsequent MV and ECMO requirements. Further, multivariate analyses were performed following adjustment for Acute Physiology and Chronic Health Evaluation (APACHE) II scores. Results: At ICU admission, the risk factors for subsequent MV identified were: higher age (Odds Ratio (OR) 1.04, 95% Confidence Interval (CI) 1.00–1.08, P = 0.03), higher values of APACHE II score (OR 1.20, 95% CI 1.08–1.33, P < 0.001), Sequential Organ Failure Assessment score (OR 1.53, 95% CI 1.18–1.97, P < 0.001), lactate dehydrogenase (LDH) (OR 1.01, 95% CI 1.00–1.02, p<0.001) and C-reactive protein (OR 1.09, 95% CI 1.00–1.19, P = 0.04), and lower values of lymphocytes (OR 1.00, 95% CI 1.00–1.00, P = 0.02) and antithrombin (OR 0.95, 95% CI 0.91–0.95, P < 0.01). Patients who subsequently required ECMO showed lower values of estimated glomerular filtration rate (OR 0.98, 95% CI 0.96–1.00, P = 0.04) and antithrombin (OR 0.94, 95% CI 0.88–1.00, P = 0.03) at ICU admission. Multivariate analysis showed that higher body mass index (OR 1.19, 95% CI 1.00–1.40, P = 0.04) and higher levels of LDH (OR 1.01, 95% CI 1.01–1.02, P < 0.01) were independent risk factors for the need for MV. Lower level of antithrombin (OR 0.94, 95% CI 0.88–1.00, P = 0.03) was a risk factor for the need for ECMO. Conclusion: We showed that low antithrombin level at ICU admission might be a risk factor for subsequent ECMO requirements, in addition to other previously reported factors.
- Open Access
- 19 September 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 126, 145-147
Corynebacterium ulcerans pneumonia treated with venovenous extracorporeal membrane oxygenation: a case report
- 19 September 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 126, 145-147
Open AccessCorynebacterium ulcerans pneumonia treated with venovenous extracorporeal membrane oxygenation: a case report
- Open Access
- 28 February 2022
- Published by Springer Nature in Research Square
Clinical efficacy of a systematic lung-protective protocol for COVID-19 pneumonia requiring invasive ventilation: A single-center retrospective study
Background The benefits of introducing a systematic lung-protective protocol for patients with coronavirus disease (COVID-19) pneumonia and who require invasive ventilation in the intensive care unit (ICU) are unknown. Herein, we aimed to evaluate the clinical effects of introducing such a protocol in the context of mortality, duration of ventilation, and length of ICU stay. Methods In this single-center, retrospective, quality comparison study, we identified patients with COVID-19 pneumonia who received invasive ventilation in our ICU between February 2020 and October 2021. We established a systematic lung-protective protocol for the pre-introduction group until March 2021 and the post-introduction group after April 2021. Patients who did not receive invasive ventilation and who underwent veno-venous extracorporeal membrane oxygenation in a referring hospital were excluded. We collected patient characteristics at the time of ICU admission, including age, sex, body mass index (BMI), comorbidities, sequential organ failure assessment (SOFA) score, acute physiology and chronic health evaluation II (APACHE II) score, and Murray score. The study outcomes were ICU mortality, length of ICU stay, and duration of ventilation. Results The pre-introduction and post-introduction groups included 18 and 50 patients, respectively. No significant differences were observed in sex, BMI, SOFA score, APACHE II score, and Murray score; however, age was lower in the post-introduction group (70 vs. 56, p = 0.003). The introduction of this protocol did not improve ICU mortality. However, it reduced the ICU length of stay (26 days vs. 11 days, p = 0.003) and tended to shorten the duration of ventilation (15 days vs. 10 days, p = 0.06). Conclusions The introduction of the protocol was associated with a decrease in the length of ICU stay and duration of ventilation; however, it did not change mortality. The application of the protocol could improve the security of medical resources during the COVID-19 pandemic. Further prospective multicentre studies are needed.
- 28 February 2022
- Published by Springer Nature in Research Square
Open AccessClinical efficacy of a systematic lung-protective protocol for COVID-19 pneumonia requiring invasive ventilation: A single-center retrospective study
Background The benefits of introducing a systematic lung-protective protocol for patients with coronavirus disease (COVID-19) pneumonia and who require invasive ventilation in the intensive care unit (ICU) are unknown. Herein, we aimed to evaluate the clinical effects of introducing such a protocol in the context of mortality, duration of ventilation, and length of ICU stay. Methods In this single-center, retrospective, quality comparison study, we identified patients with COVID-19 pneumonia who received invasive ventilation in our ICU between February 2020 and October 2021. We established a systematic lung-protective protocol for the pre-introduction group until March 2021 and the post-introduction group after April 2021. Patients who did not receive invasive ventilation and who underwent veno-venous extracorporeal membrane oxygenation in a referring hospital were excluded. We collected patient characteristics at the time of ICU admission, including age, sex, body mass index (BMI), comorbidities, sequential organ failure assessment (SOFA) score, acute physiology and chronic health evaluation II (APACHE II) score, and Murray score. The study outcomes were ICU mortality, length of ICU stay, and duration of ventilation. Results The pre-introduction and post-introduction groups included 18 and 50 patients, respectively. No significant differences were observed in sex, BMI, SOFA score, APACHE II score, and Murray score; however, age was lower in the post-introduction group (70 vs. 56, p = 0.003). The introduction of this protocol did not improve ICU mortality. However, it reduced the ICU length of stay (26 days vs. 11 days, p = 0.003) and tended to shorten the duration of ventilation (15 days vs. 10 days, p = 0.06). Conclusions The introduction of the protocol was associated with a decrease in the length of ICU stay and duration of ventilation; however, it did not change mortality. The application of the protocol could improve the security of medical resources during the COVID-19 pandemic. Further prospective multicentre studies are needed.
- 1 December 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
Simple Optimum Energy Management Control System for Small Fuel Cell Vehicle Regarding Remaining Hydrogen and Distance to Destination
There are currently not so many Hydrogen re-fueling stations available for fuel cell vehicles (FCVs), so there is range anxiety - the concern about reaching a re-fueling station before the tank is empty. It is proposed to implement a simple optimum energy management control system for small FCVs in order to address this concern. A one person electric vehicle with a 1kW fuel cell has been developed for university education purposes. The proposed control algorithm for this vehicle periodically determines the optimum cruising velocity, based on the remaining Hydrogen fuel volume and the distance to the destination. The FCV must be able to reach its destination before consuming all of its Hydrogen fuel. This paper will introduce the concept of the optimum energy management control for FCVs; the calculation algorithm for the optimum cruising velocity; and the running simulation results.
- 1 December 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
Simple Optimum Energy Management Control System for Small Fuel Cell Vehicle Regarding Remaining Hydrogen and Distance to Destination
There are currently not so many Hydrogen re-fueling stations available for fuel cell vehicles (FCVs), so there is range anxiety - the concern about reaching a re-fueling station before the tank is empty. It is proposed to implement a simple optimum energy management control system for small FCVs in order to address this concern. A one person electric vehicle with a 1kW fuel cell has been developed for university education purposes. The proposed control algorithm for this vehicle periodically determines the optimum cruising velocity, based on the remaining Hydrogen fuel volume and the distance to the destination. The FCV must be able to reach its destination before consuming all of its Hydrogen fuel. This paper will introduce the concept of the optimum energy management control for FCVs; the calculation algorithm for the optimum cruising velocity; and the running simulation results.
- Open Access
- 1 January 2015
- Published by Crop Science Society of Japan in Japanese Journal of Crop Science
- Vol. 84 (4) , 432-438
Evaluating Canopy Color in Paddy Rice using Digital Cameras
- 1 January 2015
- Published by Crop Science Society of Japan in Japanese Journal of Crop Science
- Vol. 84 (4) , 432-438
Open AccessEvaluating Canopy Color in Paddy Rice using Digital Cameras
- 1 October 2014
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 19388756,p. 1-6
Control System of Series Hybrid Electric Vehicle with Plant Oil Electric Generator
We are proposing a new hybrid electric vehicle with a plant oil electric generator. The intention of the proposed system is to avoid the use of non- renewable fossil fuels. Plant oil is more ecological, and allows for a carbon neutral system to be created in its production. Plant oils, such as straight vegetable oil (SVO) and waste vegetable oil (WVO), are promising alternatives used in order to reduce fuel cost. A series hybrid system is proposed in which a diesel engine rotates an electric generator using SVO and WVO. The electric vehicle operates using the generated electricity. The generated electricity is also able to be charged in batteries, which can also power the electric vehicle. Other natural energy sources may also be used to charge the batteries. In this paper, we will discuss the concept and control system of the proposed series hybrid electric vehicle system using plant oil, and will provide the some experimental results.
- 1 October 2014
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- No. 19388756,p. 1-6
Control System of Series Hybrid Electric Vehicle with Plant Oil Electric Generator
We are proposing a new hybrid electric vehicle with a plant oil electric generator. The intention of the proposed system is to avoid the use of non- renewable fossil fuels. Plant oil is more ecological, and allows for a carbon neutral system to be created in its production. Plant oils, such as straight vegetable oil (SVO) and waste vegetable oil (WVO), are promising alternatives used in order to reduce fuel cost. A series hybrid system is proposed in which a diesel engine rotates an electric generator using SVO and WVO. The electric vehicle operates using the generated electricity. The generated electricity is also able to be charged in batteries, which can also power the electric vehicle. Other natural energy sources may also be used to charge the batteries. In this paper, we will discuss the concept and control system of the proposed series hybrid electric vehicle system using plant oil, and will provide the some experimental results.